Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.85%27.05B | -0.76%28.81B | -2.82%24.8B | 4.08%113.5B | 12.20%32.65B | -0.13%26.3B | 3.60%29.03B | -0.30%25.52B | 2.28%109.05B | -3.21%29.1B |
Cost of revenue | 1.68%18.6B | 0.49%20.77B | -0.85%17.83B | 4.25%79.48B | 8.69%22.54B | 0.52%18.29B | 5.30%20.67B | 1.71%17.98B | 1.20%76.24B | -3.67%20.74B |
Gross profit | 5.48%8.45B | -3.86%8.04B | -7.51%6.97B | 3.68%34.02B | 20.89%10.11B | -1.57%8.01B | -0.36%8.36B | -4.81%7.54B | 4.87%32.81B | -2.05%8.36B |
Operating expense | -8.93%5.32B | -7.75%5.26B | -9.69%5.09B | 4.07%23B | 7.57%5.83B | 5.11%5.84B | 2.48%5.7B | 1.22%5.63B | 3.36%22.1B | -6.86%5.42B |
Operating profit | 44.41%3.13B | 4.47%2.78B | -1.05%1.89B | 2.88%11.02B | 45.40%4.28B | -15.99%2.16B | -5.94%2.66B | -19.05%1.91B | 8.15%10.71B | 8.23%2.95B |
Net non-operating interest income (expenses) | 33.33%-12M | 57.14%-9M | 40.00%-9M | 1.41%-70M | 23.81%-16M | -5.88%-18M | -23.53%-21M | 6.25%-15M | 4.05%-71M | 0.00%-21M |
Non-operating interest income | 20.00%6M | 16.67%7M | 0.00%6M | 25.00%20M | 0.00%3M | 66.67%5M | 20.00%6M | 20.00%6M | 0.00%16M | 0.00%3M |
Non-operating interest expense | -21.74%18M | -40.74%16M | -28.57%15M | 3.45%90M | -20.83%19M | 15.00%23M | 22.73%27M | 0.00%21M | -3.33%87M | 0.00%24M |
Net investment income | -52.53%169M | 78.50%191M | 38.02%265M | -15.14%779M | 63.16%124M | 7.88%356M | -61.92%107M | -16.88%192M | 55.86%918M | -28.30%76M |
Gain(Loss) on financial instruments designated as cash flow hedges | 0 | -78M | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 407.69%330M | 52.33%751M | 32.78%640M | 150.00%65M | 147.06%24M | -38.89%22M | 131.18%493M | 48,300.00%482M | ||
Income from associates and other participating interests | -100.00%-4M | -50.00%2M | 6M | -57.14%6M | -33.33%4M | -2M | 33.33%4M | 0 | 102.07%14M | 50.00%6M |
Special income (charges) | 7.92%-93M | -216.92%-76M | 12.00%28M | 7.78%-1.03B | 17.61%-1.02B | -488.46%-101M | -30.85%65M | 25M | -140.32%-1.12B | -134.75%-1.24B |
Less:Restructuring and mergern&acquisition | -377.23%-280M | 261.90%76M | --0 | -31.88%438M | -54.74%291M | --101M | --21M | --25M | 119.99%643M | 118.08%643M |
Less:Impairment of capital assets | ---- | ---- | ---- | -13.04%20M | ---- | ---- | ---- | ---- | 0.00%23M | ---- |
Less:Other special charges | --0 | --0 | 44.00%-28M | 39.17%-73M | --63M | --0 | ---86M | ---50M | -128.50%-120M | --0 |
Less:Write off | ---- | ---- | ---- | -50.09%263M | ---- | ---- | ---- | ---- | --527M | ---- |
Less:Negative goodwill immediately recognized | ---- | ---- | ---- | 751.11%383M | ---- | ---- | ---- | ---- | --45M | ---- |
Other non-operating income (expenses) | -168.75%-43M | 73.58%-14M | -244.44%-39M | -145.83%-77M | -159.32%-35M | 40.74%-16M | -182.81%-53M | -62.50%27M | 147.06%168M | 410.53%59M |
Income before tax | 41.81%3.47B | 0.24%2.88B | 2.93%2.14B | 2.35%11.37B | 72.24%3.98B | -15.93%2.45B | -10.54%2.87B | -22.54%2.08B | 1.05%11.11B | -63.64%2.31B |
Income tax | -47.12%431M | 1.14%976M | -48.90%326M | -6.96%3.59B | 23.27%1.18B | -13.48%815M | -13.14%965M | -25.47%638M | 53.35%3.86B | 50.95%954M |
Net income | 86.28%3.04B | -0.21%1.9B | 25.90%1.81B | 7.31%7.78B | 106.72%2.8B | -17.15%1.63B | -9.07%1.9B | -21.23%1.44B | -14.51%7.25B | -76.31%1.36B |
Net income continuous operations | 86.17%3.04B | -0.21%1.9B | 25.88%1.81B | 7.31%7.78B | 106.72%2.8B | -17.10%1.63B | -9.16%1.9B | -21.17%1.44B | -14.50%7.25B | -76.31%1.36B |
Noncontrolling interests | -75.86%14M | -20.93%34M | 130.77%4M | 497.06%135M | 122.82%47M | -6.45%58M | -53.26%43M | -172.22%-13M | -120.00%-34M | -2,160.00%-206M |
Net income attributable to the company | 92.25%3.03B | 0.32%1.87B | 24.42%1.81B | 4.94%7.64B | 76.38%2.76B | -17.54%1.58B | -7.14%1.86B | -19.62%1.45B | -12.34%7.28B | -72.64%1.56B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 92.25%3.03B | 0.32%1.87B | 24.42%1.81B | 4.94%7.64B | 76.38%2.76B | -17.54%1.58B | -7.14%1.86B | -19.62%1.45B | -12.34%7.28B | -72.64%1.56B |
Gross dividend payment | ||||||||||
Basic earnings per share | 96.91%43.91 | 2.89%27.05 | 27.61%26.25 | 7.97%108.55 | 77.83%39.39 | -16.07%22.3 | -3.49%26.29 | -16.31%20.57 | -12.63%100.54 | -71.91%22.15 |
Diluted earnings per share | 96.90%43.9092 | 2.87%27.0444 | 27.61%26.25 | 7.97%108.55 | 78.28%39.39 | -16.07%22.3 | -3.49%26.29 | -16.31%20.57 | -12.63%100.54 | -71.51%22.095 |
Dividend per share | 0 | 14.29%16 | 0 | 10.00%33 | 18.75%19 | 0 | 0.00%14 | 0 | 7.14%30 | 0.00%16 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |